Xylem (XYL) – Research Analysts’ Recent Ratings Changes

Several analysts have recently updated their ratings and price targets for Xylem (NYSE: XYL):

• 11/4/2026 – Xylem was downgraded by Argus from “buy” to “hold”.
• 10/29/2026 – Xylem was downgraded by Zacks Research from “hold” to “strong sell”.
• 10/29/2026 – Xylem had its price target lowered by UBS Group from $112.00 to $99.00. They now have a “neutral” rating on the stock.
• 10/28/2026 – Xylem was downgraded by Barclays from “overweight” to “equal weight”. They now have a $104.00 price target on the stock, down from $139.00.
• 10/28/2026 – Xylem was downgraded by Weiss Ratings from “hold (c)” to “sell (d)”.
• 10/28/2026 – Xylem was given a new $99.00 price target by Mizuho.
• 10/28/2026 – Xylem was given a new $123.00 price target by Robert W. Baird.
• 10/28/2026 – Xylem had its price target lowered by The Goldman Sachs Group from $160.00 to $138.00. They now have a “buy” rating on the stock.
• 10/28/2026 – Xylem had its price target lowered by Royal Bank Of Canada from $135.00 to $125.00. They now have an “outperform” rating on the stock.
• 10/28/2026 – Xylem is now covered by Royal Bank Of Canada. They set a “moderate buy” rating and a $125.00 price target on the stock.
• 10/28/2026 – Xylem had its price target lowered by Citigroup from $148.00 to $130.00. They now have a “buy” rating on the stock.
• 10/28/2026 – Xylem had its price target lowered by BNP Paribas Exane from $145.00 to $135.00. They now have an “outperform” rating on the stock.
• 10/28/2026 – Xylem had its price target lowered by Stifel Nicolaus from $141.00 to $114.00. They now have a “buy” rating on the stock.
• 10/28/2026 – Xylem had its price target lowered by Oppenheimer from $150.00 to $135.00. They now have an “outperform” rating on the stock.
• 10/28/2026 – Xylem was downgraded by JPMorgan Chase & Co. from “overweight” to “neutral”. They now have a $90.00 price target on the stock, down from $118.00.
• 10/19/2026 – Xylem was given a new $141.00 price target by Stifel Nicolaus.
• 10/19/2026 – Xylem had its price target lowered by JPMorgan Chase & Co. from $137.00 to $118.00. They now have a “neutral” rating on the stock.
• 10/15/2026 – Xylem had its price target lowered by Mizuho from $130.00 to $110.00. They now have a “neutral” rating on the stock.
• 10/14/2026 – Xylem had its “outperform” rating reaffirmed by Oppenheimer. They now have a $150.00 price target on the stock, down from $158.00.
• 10/14/2026 – Xylem had its price target lowered by Royal Bank Of Canada from $164.00 to $135.00. They now have an “outperform” rating on the stock.
• 10/13/2026 – Xylem had its price target lowered by Barclays from $159.00 to $139.00. They now have an “overweight” rating on the stock.
• 10/12/2026 – Xylem had its price target lowered by Citigroup from $172.00 to $148.00. They now have a “buy” rating on the stock.
• 10/5/2026 – Xylem had its price target lowered by UBS Group from $138.00 to $112.00. They now have a “neutral” rating on the stock.
• 9/15/2026 – Xylem is now covered by Wolfe Research. They set a “peer perform” rating on the stock.

Xylem Stock Performance

NYSE XYL traded up $4.69 during trading on Wednesday, reaching $100.96. The company’s stock had a trading volume of 3,749,362 shares, compared to its average volume of 2,191,836. The firm has a 50 day moving average price of $104.36 and a 200 day moving average price of $117.13. Xylem Inc. has a 12 month low of $87.40 and a 12 month high of $152.43. The firm has a market capitalization of $23.15 billion, a price-to-earnings ratio of 22.34, a price-to-earnings-growth ratio of 1.62 and a beta of 1.01. The company has a current ratio of 1.39, a quick ratio of 1.02 and a debt-to-equity ratio of 0.23.

Xylem (NYSE:XYL) last announced its earnings results on Tuesday, October 27th. The industrial products company reported $1.44 EPS for the quarter, missing the consensus estimate of $1.45 by ($0.01). The business had revenue of $2.20 billion for the quarter, compared to the consensus estimate of $2.28 billion. Xylem had a return on equity of 12.06% and a net margin of 11.94%. The firm’s revenue for the quarter was down 3.0% compared to the same quarter last year. During the same period in the prior year, the business posted $1.37 earnings per share. As a group, equities analysts anticipate that Xylem Inc. will post 5.45 EPS for the current fiscal year.

Xylem Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Thursday, September 24th. Stockholders of record on Thursday, August 27th were given a dividend of $0.43 per share. This represents a $1.72 dividend on an annualized basis and a dividend yield of 1.7%. The ex-dividend date was Thursday, August 27th. Xylem’s dividend payout ratio is presently 38.05%.

Insider Buying and Selling at Xylem

In related news, Director D Koch bought 11,000 shares of Xylem stock in a transaction dated Thursday, October 29th. The shares were bought at an average cost of $89.60 per share, with a total value of $985,600.00. Following the acquisition, the director owned 12,247 shares in the company, valued at $1,097,331.20. This trade represents a 882.12% increase in their position. The transaction was disclosed in a document filed with the SEC, which is available through this link. Insiders own 0.32% of the company’s stock.

Xylem Inc (NYSE: XYL) is a global water technology company that develops products and services for the transportation, treatment, testing and efficient use of water and wastewater. Its offerings support municipal water and wastewater utilities, industrial customers, commercial facilities and residential applications.

The company’s products and solutions include water and wastewater pumps, treatment systems, dewatering equipment, smart meters, monitoring and control technologies, leak detection tools, and data-driven analytics.